GlassScriptPhysician profile
Timolyne Skinner
NPI 1831300524
$9,630.41
in general payments reported to CMS, 2019-2025
39 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,543 · 2022: $2,400 · 2023: $2,147 · 2024: $1,863 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,688.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,046.48 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $1,008.62 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $637.12 | 2021-2025 | |
| Glaxosmithkline, LLC. | $590.79 | 2021-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $492.87 | 2021-2025 | Jardiance |
| Pfizer INC. | $485.24 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $456.14 | 2021-2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $455.99 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $349.35 | 2021-2022 | |
| Exact Sciences Corporation | $343.20 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $334.77 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $300.74 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $267.54 | 2021-2023 | Belsomra, Steglatro, Januvia |
| Amgen INC. | $250.05 | 2022-2025 | Repatha, Otezla, Krystexxa |
| Abbott Laboratories | $234.94 | 2021-2023 | Freestyle Libre 3 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timolyne Skinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.